Author

Bo Li

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & TechnologyORCID 0000-0003-2914-9178Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bo Li20 papers · Children's Hospital of Philadelphia

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Chung-Wei FuiD· 1 shared Connor C. WangiD· 1 shared James M. BurkeiD· 1 shared Jiajun DongiD· 1 shared Joshua Parker· 1 shared Skyler A. BriggsiD· 1 shared Thomas J. KodadekiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Chung-Wei FuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Macrocyclic Peptides Containing an Imidazopyridinium (IP+) Unit Display Enhanced Passive Cell Permeability

Bo Li, Joshua Parker, Skyler A. Briggs, Jiajun Dong, Connor C. Wang, Chung-Wei Fu, James M. Burke, Thomas J. Kodadek

This study shows that adding an imidazopyridinium (IP+) unit to macrocyclic peptides enhances their passive membrane permeability, enabling them to enter cells and inhibit intracellular targets like p53-MDM2.

Journal of the American Chemical Society · Mar 6, 2026Peer-reviewedBiochemistry